Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Aqilion AB (publ) (Sweden)
Homepage:
aqilion.com
Alternate names:
Aqilion,
Aqilion AB,
Aqilion AB (publ)
ROR:
02y9jg163
OpenAlex ID:
I4405267475
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
2021
·
Kristina Witt
, Susan Evans-Axelsson
, et al.
·
Cancer Immunology Immunotherapy
·
37
PDF
Creating Glepaglutide, the First Long-Acting GLP-2 Analogue to Enable a Ready-to-Use Injection
2025
·
Bjarne Due Larsen
, Jesper Skodborg Villadsen
, et al.
·
Journal of Medicinal Chemistry
·
6
Creating Glepaglutide: The First Long-Acting GLP-2 Analogue to enable a Ready-to-Use Subcutaneous Injection
2025
·
Bjarne Due Larsen
, Jesper Skodborg Villadsen
, et al.
·
Intestinal failure.
PDF
Show more works
View as search
Works count:
3
Citation count:
43
Year
Topic
Type